Douglas M. Lankler
Senior Vice President, Pfizer.
Companies
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 25, 2026Shares withheld for tax 116,811 shares at $26.92 of Pfizer2
- Feb 25, 2026Shares withheld for tax 2,198 shares at $27.09 of Pfizer2
- Feb 25, 2026Exercised options 122,907 shares at $33.82 of Pfizer2
- Feb 27, 2025Shares withheld for tax 146,961 shares at $26.06 of Pfizer3
- Feb 27, 2025Shares withheld for tax 3,589 shares at $26.10 of Pfizer3
- Feb 27, 2025Exercised options 156,914 shares at $31.31 of Pfizer3
- Feb 22, 2025Shares withheld for tax 76,565 shares at $26.08 of Pfizer4
- Feb 22, 2025Shares withheld for tax 3,334 shares at $26.30 of Pfizer4
- Feb 22, 2025Exercised options 85,824 shares at $30.17 of Pfizer4
- Feb 23, 2024Shares withheld for tax 77,384 shares at $27.37 of Pfizer5
- Feb 23, 2024Shares withheld for tax 6,618 shares at $27.76 of Pfizer5
- Feb 23, 2024Exercised options 95,755 shares at $27.34 of Pfizer5
- Feb 25, 2023Shares withheld for tax 26,389 shares at $41.75 of Pfizer6
- Feb 22, 2023Shares withheld for tax 19,878 shares at $42.38 of Pfizer7
- Dec 14, 2022Exercised options 47,472 shares at $30.17 of Pfizer8
- Dec 14, 2022Exercised options 54,186 shares at $22.89 of Pfizer8
- May 12, 2022Sold 38,273 shares at $49.41 of Pfizer9
- Feb 26, 2022Shares withheld for tax 36,282 shares at $50.64 of Pfizer10
- Feb 26, 2022Shares withheld for tax 21,149 shares at $47.72 of Pfizer10
- Feb 26, 2022Exercised options 77,709 shares at $25.60 of Pfizer10
- Feb 23, 2022Shares withheld for tax 57,090 shares at $51.28 of Pfizer11
- Feb 23, 2022Shares withheld for tax 27,771 shares at $46.87 of Pfizer11
- Feb 23, 2022Exercised options 115,342 shares at $27.34 of Pfizer11
- Nov 26, 2021Sold 6,400 shares at $54.30 of Pfizer12
- Nov 26, 2021Sold 5,856 shares at $54.31 of Pfizer12
Trade performance
| Date | Stock | Trade | Value | Return since | Vs S&P since | Vs S&P, 1 year |
|---|---|---|---|---|---|---|
| May 12, 2022 | PFE | Sale | $1.9M | −41.6% | +138.3% | +30.8% |
| Nov 26, 2021 | PFE | Sale | $2.2M | −45.5% | +113.6% | −5.5% |
| Apr 29, 2020 | PFE | Sale | $2.5M | −18.6% | +181.8% | +36.5% |
| Feb 1, 2019 | PFE | Sale | $213.8K | −27.6% | +213.4% | +32.5% |
| Jan 30, 2019 | PFE | Sale | $1.6M | −25.4% | +213.8% | +33.3% |
Returns are price-only (no dividends), measured from the trade date.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARPfizer, Senior Vice President
- 2
- 3SEC EDGARForm 4 filed Mar 3, 2025
- 4SEC EDGARForm 4 filed Feb 25, 2025
- 5SEC EDGARForm 4 filed Feb 27, 2024
- 6SEC EDGARForm 4 filed Feb 28, 2023
- 7SEC EDGARForm 4 filed Feb 24, 2023
- 8SEC EDGARForm 4 filed Dec 16, 2022
- 9SEC EDGARForm 4 filed May 13, 2022
- 10SEC EDGARForm 4 filed Mar 1, 2022
- 11SEC EDGARForm 4 filed Feb 25, 2022
- 12SEC EDGARForm 4 filed Nov 30, 2021